Silent cerebral damage in hypertension

Current Hypertension Reviews

Volumn 3, Issue 2, 2007, Pages 83-88

  Sierra, Cristina ^a   Coca, Antonio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Hypertension related cognitive changes; Aortic atherosclerosis; Brain MRI; Cerebral white matter lesions; High blood pressure

Indexed keywords

ANTIHYPERTENSIVE AGENT; PERINDOPRIL; PLACEBO;

AGING; ANTIHYPERTENSIVE THERAPY; AUTOREGULATION; BLOOD PRESSURE VARIABILITY; BRAIN BLOOD FLOW; BRAIN CIRCULATION; BRAIN DAMAGE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEMODYNAMICS; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; RISK REDUCTION; WHITE MATTER;

EID: 34248638785     PISSN: 15734021     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340207780598509     Document Type: Review

References (54)

1. Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger's report. Stroke 1995; 26: 1293-1301.
2. Shimada K, Kawamoto A, Matsubayashi K, Ozawa T. Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure. Hypertension 1990; 16: 692-699.
3. Liao D, Cooper L, Cai J, et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Stroke 1996; 27: 2262-2270.
4. Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996; 27: 130-135.
5. Sierra C, Coca A, Gómez-Angelats E, Poch E, Sobrino J, de la Sierra A. Renin-angiotensin system genetic polymorphisms and cerebral white matter lesions in essential hypertension. Hypertension 2002; 39: 343-347.
6. van Swieten JC, Kapelle LJ, Algra A, van Latum JC, Koudstaal PJ, van Gijn J. Hypodensity of the cerebral white matter in patients with transient ischemic attack or minor stroke: influence on the rate of subsequent stroke. Dutch TIA Trial Study Group. Ann Neurol 1992; 32: 177-183.
7. De Groot JC, de Leeuw FE, Oudkerk M, et al. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol 2002; 52: 335-341.
8. Bots ML, van Swieten JC, Breteler MMB, et al. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet 1993; 341: 1232-1237.
9. de Leeuw FE, de Groot JC, Oudkerk M, et al. Aortic atherosclerosis at middle age predicts cerebral white matter lesions in the elderly. Stroke 2000; 31: 425-429.
10. Carmelli D, DeCarli C, Swan GE, et al. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke 1998; 29: 1177-1181.
11. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis. A review. Stroke 1997; 28: 652-659.
12. Kuwabara Y, Ichiya Y, Sasaki M, et al. Cerebral blood flow and vascular response to hypercapnia in hypertensive patients with leukoaraiosis. Ann Nucl Med 1996; 10; 293-298.
13. Bakker SLM, de Leeuw FE, de Groot JC, Hofman A, Koudstaal PJ, Breteler MMB. Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly. Neurology 1999; 52: 578-583.
14. Chamorro A, Pujol J, Saiz A, et al. Periventricular white matter lucencies in patients with lacunar stroke. Arch Neurol 1997; 54: 1284-1288.
15. Sierra C, de la Sierra A, Chamorro A, Larrousse M, Domenech M, Coca A. Cerebral hemodynamics and silent cerebral white matter lesions in middle-aged essential hypertensive patients. Blood Press 2004; 13: 304-309.
16. O'Sullivan M, Lythgoe DJ, Pereira AC, et al. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 2002; 59: 321-326.
17. Longstreth WT, Manolio TA, Arnold A, et al. for the Cardiovascular Health Study Collaborative Research Group. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996; 27: 1274-1282.
18. Breteler MMB, van Swieten JC, Bots ML, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: The Rotterdam Study. Neurology 1994; 44:1246-1252.
19. Goldstein IB, Bartzokis G, Hance DB, Shapiro D. Relationship between blood pressure and subcortical lesions in healthy elderly people. Stroke 1998; 29: 765-772.
20. Sierra C, de la Sierra A, Mercader J, Gómez-Angelats E, Urbano-Márquez A, Coca A. Silent cerebral white matter lesions in middle-aged essential hypertensive patients. J Hypertens 2002; 20: 519-524.
21. Dufouil C, de Kersaint-Gilly A, Besancon V, et al. Longitudinal study on blood pressure and white matter hyperintensities. The EVA MRI cohort. Neurology 2001; 56: 921-926.
22. van Dijk EJ, Breteler MM, Schmidt R, et al. CASCADE Consortium. The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study. Hypertension. 2004; 44: 625-630.
23. Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F. Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study. Lancet 2003; 361: 2046-2048.
24. Dufouil C, Chalmers J, Coskun O, et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke. The PROGRESS Magnetic resonance imaging substudy. Circulation 2005; 112: 1644-1650.
25. Kannel WB, Wolf PA, Verter MS, McNamara PM. Epidemiologic assessment of the role of blood pressure in stroke. The Framingham Study. JAMA 1970; 214: 301-310.
26. Wong TY, Klein R, Sharrett AR, et al. Retinal microvascular abnormalities and cognitive impairment in middle-aged persons. The Atherosclerosis Risk in Communities Study. Stroke 2002; 33: 1487-1492.
27. Cacciatore F, Abete P, Ferrara N, et al. The role of blood pressure in cognitive impairment in an elderly population. J Hypertens 1997; 15: 135-142.
28. Elias MF, Wolf PA, D'Agostino RB, Cobb J, White LR. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol 1993; 138: 353-364.
29. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ. The association between midlife blood pressure levels and late-life cognitive function. JAMA 1995; 274: 1846-1851.
30. Kilander L, Nyman H, Boberg K Hansson L, Lithell H. Hypertension is related to cognitive impairment; a 20-year follow-up of 999 men. Hypertension 1998; 31: 780-786.
31. Carmelli D, Swan GE, Reed T, et al. Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins. Neurology 1998; 50: 1580-1585.
32. Farmer ME, Kittner SJ, Abbott RD, Wolz MM, Wolf PA, White LR. Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study. J Clin Epidemiol 1990; 43: 475-480.
33. Forette F, Seux ML, Staessen JA, et al. The prevention of dementia with antihypertensive treatment. New evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 2002; 162: 2046-2052.
34. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MMB. Silent brain infarcts and white matter lesions increase stroke risk in the general population. The Rotterdam Scan Study. Stroke 2003; 34: 1126-1129.
35. Kuller LH, Longstreth WT, Arnold AM, Bernick C, Bryan N, Beauchamp NJ, for the Cardiovascular Health Study Collaborative Research Group. White matter hyperintensity on cranial magnetic resonance imaging. A predictor of stroke. Stroke 2004; 35: 1821-1825.
36. Fu JH, Lu CZ, Hong Z, Dong Q, Luo Y, Wong KS. Extent of white matter lesions is related to acute subcortical infarcts and predicts further stroke risk in patients with first ever ischemic stroke. J Neurol Neurosurg Psychiatry 2005; 76: 793-796.
37. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral white matter lesions and the risk of dementia. Arch Neurol 2004; 61: 1531-1534.
38. Schmidt R, Fazekas F, Offenbacher H, et al. Magnetic resonance imaging white matter lesions and cognitive impairment in hypertensive individuals. Arch Neurol 1991; 48: 417-420.
39. De Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: The Rotterdam Scan Study. Ann Neurol 2000; 47: 145-151.
40. Sierra C, de la Sierra A, Salamero M, Gómez-Angelats E, Sobrino J, Coca A. Silent cerebral white matter lesions and cognitive function in middle-aged essential hypertensive patients. Am J Hypertens 2004; 17: 529-534.
41. Kuller LH, Lopez OL, Newman A, et al. Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology 2003; 22: 13-22.
42. Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347: 1141-1145.
43. Swan GE, DeCarli C, Miller BL, et al. Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology 1998; 51: 986-993.
44. Casale PN, Devereux RB, Milner M, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173-178.
45. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352.
46. Bikkina M, Levy D, Evans JC, et al. Left ventricular mass and risk of stroke in an elderly cohort: The Framingham Heart Study. JAMA 1994; 272: 33-36.
47. Shigematsu Y, Hamada M, Ohtsuka T, et al. Left ventricular geometry as an Wependent predictor for extracardiac target organ damage in essential hypertension. Am J Hypertens 1998; 11: 1171-1177.
48. Pontremolli R, Ravera M, Bezante GP, et al. Left ventricular geometry and function in patients with essential hypertension and microalbuminuria. J Hypertens 1999; 17: 993-1000.
49. Lindgren A, Roijer A, Rudling O, et al. Cerebral lesions on magnetic resonance imaging, heart disease, and vascular risk factors in subjects without stroke. A population-based study. Stroke 1994; 25: 929-934.
50. Longstreth WT, Manolio TA, Arnold A, et al., for the Cardiovascular Health Study Collaborative Research Group. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996; 27: 1274-1282.
51. Schmidt R, Hayn M, Fazekas F, Kapeller P, Esterbauer H. Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals. Correlations with plasma concentrations of naturally occurring antioxidants. Stroke 1996; 27: 2043-2047.
52. Kohara K, Zhao B, Jiang Y, et al. Relation of left ventricular hypertrophy and geometry to asymptomatic cerebrovascular damage in essential hypertension. Am J Cardiol 1999; 83: 367-370.
53. Sierra C, de la Sierra A, Paré JC, Gómez-Angelats E, Coca A. Correlation between silent cerebral white matter lesions and left ventricular mass and geometry in essential hypertension. Am J Hypertens 2002; 15: 507-512.
54. Lee S, Park S, Ki H, et al. Prevalence and risk factors of silent cerebral infarction in apparently normal adults. Hypertension 2000; 36: 73-77.